Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > UK. G. BCMA MAb mcMMAF>

---

UK. G. BCMA MAb mcMMAF>'s subsections
(*) EU CE Mark Date: 2020. 08.26
(*) Israel Approval Date: ?
>Conjugate for Injection
BCMA: B-cell maturation antigen
Company
Generic Name: belantamab mafodotin-
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2022. 02.01
Product Web-Site

UK. G. BCMA MAb mcMMAF>'s products
This section has no products